Why the study?
Is biologically defined aspirin resistance associated with increased risk for cardiovascular events in patients with stable coronary artery disease?
Population
Patients with stable coronary artery disease with and without a history of myocardial infarction
Design
Other
Authors
Loading...
Findings do not support aspirin resistance testing in stable CAD; leaves open prognostic value, especially by sex.
Is biologically defined aspirin resistance associated with increased risk for cardiovascular events in patients with stable coronary artery disease?
Additional large studies are needed to determine if aspirin resistance increases cardiovascular risk in stable CAD patients, particularly regarding sex differences.
Dorsch et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: